The global market for Major Depressive Disorder (MDD) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood that interferes with the person"s ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression. The common symptoms of this mental disorder are insomnia, loss of interest, recurrent thoughts of death, feelings of worthlessness and reduced ability to think. The rising prevalence of major depression has led to a sharp increase in the patient volume suffering from depression. Currently, many treatments and therapies are available for major depression but the market still holds a large scope of growth opportunities with high unmet needs of the market.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

This report aims to provide a comprehensive presentation of the global market for Major Depressive Disorder (MDD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Major Depressive Disorder (MDD).

The Major Depressive Disorder (MDD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Major Depressive Disorder (MDD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Major Depressive Disorder (MDD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Major Depressive Disorder (MDD) Market Report

Report Metric	Details
Report Name	Major Depressive Disorder (MDD) Market
Segment by Type	Antidepressant Drugs SSRIs SNRIs Benzodiazepines Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Eli Lily, Johnson & Johnson, Forest Laboratories, Sanofi-Aventis, H. Lundbeck, Bristol-Myers Squibb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Major Depressive Disorder (MDD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Major Depressive Disorder (MDD) Market report?

Ans: The main players in the Major Depressive Disorder (MDD) Market are Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Eli Lily, Johnson & Johnson, Forest Laboratories, Sanofi-Aventis, H. Lundbeck, Bristol-Myers Squibb

What are the Application segmentation covered in the Major Depressive Disorder (MDD) Market report?

Ans: The Applications covered in the Major Depressive Disorder (MDD) Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Major Depressive Disorder (MDD) Market report?

Ans: The Types covered in the Major Depressive Disorder (MDD) Market report are Antidepressant Drugs, SSRIs, SNRIs, Benzodiazepines, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antidepressant Drugs

1.2.3 SSRIs

1.2.4 SNRIs

1.2.5 Benzodiazepines

1.2.6 Others

1.3 Market by Application

1.3.1 Global Major Depressive Disorder (MDD) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Major Depressive Disorder (MDD) Market Perspective (2020-2031)

2.2 Global Major Depressive Disorder (MDD) Growth Trends by Region

2.2.1 Global Major Depressive Disorder (MDD) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Major Depressive Disorder (MDD) Historic Market Size by Region (2020-2025)

2.2.3 Major Depressive Disorder (MDD) Forecasted Market Size by Region (2026-2031)

2.3 Major Depressive Disorder (MDD) Market Dynamics

2.3.1 Major Depressive Disorder (MDD) Industry Trends

2.3.2 Major Depressive Disorder (MDD) Market Drivers

2.3.3 Major Depressive Disorder (MDD) Market Challenges

2.3.4 Major Depressive Disorder (MDD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Major Depressive Disorder (MDD) Players by Revenue

3.1.1 Global Top Major Depressive Disorder (MDD) Players by Revenue (2020-2025)

3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Players (2020-2025)

3.2 Global Major Depressive Disorder (MDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Major Depressive Disorder (MDD) Revenue

3.4 Global Major Depressive Disorder (MDD) Market Concentration Ratio

3.4.1 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder (MDD) Revenue in 2024

3.5 Global Key Players of Major Depressive Disorder (MDD) Head office and Area Served

3.6 Global Key Players of Major Depressive Disorder (MDD), Product and Application

3.7 Global Key Players of Major Depressive Disorder (MDD), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Major Depressive Disorder (MDD) Breakdown Data by Type

4.1 Global Major Depressive Disorder (MDD) Historic Market Size by Type (2020-2025)

4.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2026-2031)

5 Major Depressive Disorder (MDD) Breakdown Data by Application

5.1 Global Major Depressive Disorder (MDD) Historic Market Size by Application (2020-2025)

5.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Major Depressive Disorder (MDD) Market Size (2020-2031)

6.2 North America Major Depressive Disorder (MDD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Major Depressive Disorder (MDD) Market Size by Country (2020-2025)

6.4 North America Major Depressive Disorder (MDD) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Major Depressive Disorder (MDD) Market Size (2020-2031)

7.2 Europe Major Depressive Disorder (MDD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Major Depressive Disorder (MDD) Market Size by Country (2020-2025)

7.4 Europe Major Depressive Disorder (MDD) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size (2020-2031)

8.2 Asia-Pacific Major Depressive Disorder (MDD) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2020-2025)

8.4 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Major Depressive Disorder (MDD) Market Size (2020-2031)

9.2 Latin America Major Depressive Disorder (MDD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Major Depressive Disorder (MDD) Market Size by Country (2020-2025)

9.4 Latin America Major Depressive Disorder (MDD) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size (2020-2031)

10.2 Middle East & Africa Major Depressive Disorder (MDD) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2020-2025)

10.4 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Major Depressive Disorder (MDD) Introduction

11.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Major Depressive Disorder (MDD) Introduction

11.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.2.5 GlaxoSmithKline Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Major Depressive Disorder (MDD) Introduction

11.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.3.5 Merck Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Major Depressive Disorder (MDD) Introduction

11.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.4.5 AstraZeneca Recent Development

11.5 Eli Lily

11.5.1 Eli Lily Company Details

11.5.2 Eli Lily Business Overview

11.5.3 Eli Lily Major Depressive Disorder (MDD) Introduction

11.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.5.5 Eli Lily Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Major Depressive Disorder (MDD) Introduction

11.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.6.5 Johnson & Johnson Recent Development

11.7 Forest Laboratories

11.7.1 Forest Laboratories Company Details

11.7.2 Forest Laboratories Business Overview

11.7.3 Forest Laboratories Major Depressive Disorder (MDD) Introduction

11.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.7.5 Forest Laboratories Recent Development

11.8 Sanofi-Aventis

11.8.1 Sanofi-Aventis Company Details

11.8.2 Sanofi-Aventis Business Overview

11.8.3 Sanofi-Aventis Major Depressive Disorder (MDD) Introduction

11.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.8.5 Sanofi-Aventis Recent Development

11.9 H. Lundbeck

11.9.1 H. Lundbeck Company Details

11.9.2 H. Lundbeck Business Overview

11.9.3 H. Lundbeck Major Depressive Disorder (MDD) Introduction

11.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.9.5 H. Lundbeck Recent Development

11.10 Bristol-Myers Squibb

11.10.1 Bristol-Myers Squibb Company Details

11.10.2 Bristol-Myers Squibb Business Overview

11.10.3 Bristol-Myers Squibb Major Depressive Disorder (MDD) Introduction

11.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2020-2025)

11.10.5 Bristol-Myers Squibb Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antidepressant Drugs

Table 3. Key Players of SSRIs

Table 4. Key Players of SNRIs

Table 5. Key Players of Benzodiazepines

Table 6. Key Players of Others

Table 7. Global Major Depressive Disorder (MDD) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Major Depressive Disorder (MDD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Major Depressive Disorder (MDD) Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Major Depressive Disorder (MDD) Market Share by Region (2020-2025)

Table 11. Global Major Depressive Disorder (MDD) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Major Depressive Disorder (MDD) Market Share by Region (2026-2031)

Table 13. Major Depressive Disorder (MDD) Market Trends

Table 14. Major Depressive Disorder (MDD) Market Drivers

Table 15. Major Depressive Disorder (MDD) Market Challenges

Table 16. Major Depressive Disorder (MDD) Market Restraints

Table 17. Global Major Depressive Disorder (MDD) Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Major Depressive Disorder (MDD) Market Share by Players (2020-2025)

Table 19. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder (MDD) as of 2024)

Table 20. Ranking of Global Top Major Depressive Disorder (MDD) Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder (MDD) Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Major Depressive Disorder (MDD), Headquarters and Area Served

Table 23. Global Key Players of Major Depressive Disorder (MDD), Product and Application

Table 24. Global Key Players of Major Depressive Disorder (MDD), Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Major Depressive Disorder (MDD) Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2020-2025)

Table 28. Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2026-2031)

Table 30. Global Major Depressive Disorder (MDD) Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2020-2025)

Table 32. Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2026-2031)

Table 34. North America Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Major Depressive Disorder (MDD) Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Major Depressive Disorder (MDD) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Major Depressive Disorder (MDD) Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Major Depressive Disorder (MDD) Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Major Depressive Disorder (MDD) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Major Depressive Disorder (MDD) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Major Depressive Disorder (MDD) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Major Depressive Disorder (MDD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Major Depressive Disorder (MDD) Product

Table 52. Pfizer Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. GlaxoSmithKline Company Details

Table 55. GlaxoSmithKline Business Overview

Table 56. GlaxoSmithKline Major Depressive Disorder (MDD) Product

Table 57. GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 58. GlaxoSmithKline Recent Development

Table 59. Merck Company Details

Table 60. Merck Business Overview

Table 61. Merck Major Depressive Disorder (MDD) Product

Table 62. Merck Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 63. Merck Recent Development

Table 64. AstraZeneca Company Details

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Major Depressive Disorder (MDD) Product

Table 67. AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 68. AstraZeneca Recent Development

Table 69. Eli Lily Company Details

Table 70. Eli Lily Business Overview

Table 71. Eli Lily Major Depressive Disorder (MDD) Product

Table 72. Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 73. Eli Lily Recent Development

Table 74. Johnson & Johnson Company Details

Table 75. Johnson & Johnson Business Overview

Table 76. Johnson & Johnson Major Depressive Disorder (MDD) Product

Table 77. Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 78. Johnson & Johnson Recent Development

Table 79. Forest Laboratories Company Details

Table 80. Forest Laboratories Business Overview

Table 81. Forest Laboratories Major Depressive Disorder (MDD) Product

Table 82. Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 83. Forest Laboratories Recent Development

Table 84. Sanofi-Aventis Company Details

Table 85. Sanofi-Aventis Business Overview

Table 86. Sanofi-Aventis Major Depressive Disorder (MDD) Product

Table 87. Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 88. Sanofi-Aventis Recent Development

Table 89. H. Lundbeck Company Details

Table 90. H. Lundbeck Business Overview

Table 91. H. Lundbeck Major Depressive Disorder (MDD) Product

Table 92. H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 93. H. Lundbeck Recent Development

Table 94. Bristol-Myers Squibb Company Details

Table 95. Bristol-Myers Squibb Business Overview

Table 96. Bristol-Myers Squibb Major Depressive Disorder (MDD) Product

Table 97. Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2020-2025) & (US$ Million)

Table 98. Bristol-Myers Squibb Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Major Depressive Disorder (MDD) Picture

Figure 2. Global Major Depressive Disorder (MDD) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Major Depressive Disorder (MDD) Market Share by Type: 2024 VS 2031

Figure 4. Antidepressant Drugs Features

Figure 5. SSRIs Features

Figure 6. SNRIs Features

Figure 7. Benzodiazepines Features

Figure 8. Others Features

Figure 9. Global Major Depressive Disorder (MDD) Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Major Depressive Disorder (MDD) Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Others Case Studies

Figure 14. Major Depressive Disorder (MDD) Report Years Considered

Figure 15. Global Major Depressive Disorder (MDD) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Major Depressive Disorder (MDD) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Major Depressive Disorder (MDD) Market Share by Region: 2024 VS 2031

Figure 18. Global Major Depressive Disorder (MDD) Market Share by Players in 2024

Figure 19. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder (MDD) as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Major Depressive Disorder (MDD) Revenue in 2024

Figure 21. North America Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Major Depressive Disorder (MDD) Market Share by Country (2020-2031)

Figure 23. United States Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Major Depressive Disorder (MDD) Market Share by Country (2020-2031)

Figure 27. Germany Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Region (2020-2031)

Figure 35. China Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Major Depressive Disorder (MDD) Market Share by Country (2020-2031)

Figure 43. Mexico Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Country (2020-2031)

Figure 47. Turkey Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Major Depressive Disorder (MDD) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 54. Eli Lily Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 55. Johnson & Johnson Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 56. Forest Laboratories Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 57. Sanofi-Aventis Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 58. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Depressive Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Z6361

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder (MDD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9N6266

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder Therapeutic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19F13948

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Global Major Depressive Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9J1966

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions